Investors Yawn As Biotech Puts Up Positive Test Results — For 2 Patients [Investor's Business Daily]
AnaptysBio, Inc. (ANAB)
Last anaptysbio, inc. earnings: 3/2 08:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anaptysbio.com/investor-relations
Company Research
Source: Investors Business Daily
Related news 6/21/2019 AnaptysBio stock tumbled Friday after the results of a study from Regeneron Pharmaceuticals and Sanofi cast doubt on the biotech... Stocks To Watch: AnaptysBio Sees RS Rating Jump To 80 AnaptysBio Earns Relative Strength Rating Upgrade Stock Upgrades: AnaptysBio Shows Rising Relative Strength IBD Rating Upgrades: AnaptysBio Flashes Improved Price Strength Why This Rival Won't Threaten Regeneron's Potential Blockbuster Stocks Showing Market Leadership: AnaptysBio Earns 93 RS Rating Why These Biotechs Diverged On AnaptysBio's Peanut Allergy Study 100 Best Stocks Of 2017: This Group Boasted 32 AnaptysBio stock toppled Tuesday after the biotech company's psoriasis treatment failed to enthuse investors. On today's stock market , shares of AnaptysBio ( ANAB ) tumbled 10.4%, to 31.35, in above-average volume . Earlier, AnaptysBio stock crashed as much as 15.8%. The biotech company unveiled promising data for its drug, AN
Show less
Read more
Impact Snapshot
Event Time:
ANAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANAB alerts
High impacting AnaptysBio, Inc. news events
Weekly update
A roundup of the hottest topics
ANAB
News
- AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $66.00 to $36.00. They now have an "overweight" rating on the stock.MarketBeat
- AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Truist Financial Co. from $30.00 to $20.00. They now have a "hold" rating on the stock.MarketBeat
- AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.MarketBeat
- AnaptysBio Stock Down as Eczema Study Fails to Meet Goals [Yahoo! Finance]Yahoo! Finance
- AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Guggenheim from $90.00 to $36.00. They now have a "buy" rating on the stock.MarketBeat
ANAB
Earnings
- 11/5/24 - Beat
ANAB
Sec Filings
- 12/18/24 - Form SCHEDULE
- 12/11/24 - Form 8-K
- 12/3/24 - Form 4
- ANAB's page on the SEC website